[1] IANSANTE V, MITRY R R, FILIPPI C, et al. Human hepatocyte transplantation for liver disease: current status and future perspectives [J]. Pediatr Res, 2018, 83(1/2): 232-240.
[2] HUEBERT R C, RAKELA J. Cellular therapy for liver disease[J]. Mayo Clin Proc, 2014, 89(3): 414-424.
[3] WANG F, ZHOU L, MA X, et al. Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective fiveyear follow-up study[J]. Transplant Proc, 2014, 46(1): 192-198.
[4] FU G B, HUANG W J, ZENG M, et al. Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens[J]. Cell Res, 2019, 29(1): 8-22.
[5] PENG W C, LOGAN C Y, FISH M, et al. Inflammatory cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture [J]. Cell, 2018, 175(6): 1607-1619.e15.
[6] ZHANG K, ZHANG L D, LIU W M, et al. In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity[J]. Cell Stem Cell, 2018, 23(6): 806-819.e4.
[7] KIM Y, KANG K, LEE S B, et al. Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells[J]. J Hepatol, 2019, 70(1): 97-107.
[8] FENG S S, WU J Y, QIU W L, et al. Large-scale generation of functional and transplantable hepatocytes and cholangiocytes from human endoderm stem cells[J]. Cell Rep, 2020, 33(10): 108455.
[9] CHEN S T, WANG J L, REN H Z, et al. Hepatic spheroids derived from human induced pluripotent stem cells in bio-artificial liver rescue porcine acute liver failure[J]. Cell Res, 2020, 30(1): 95-97.
[10] KO S, RUSSELL J O, MOLINA L M, et al. Liver progenitors and adult cell plasticity in hepatic injury and repair: knowns and unknowns[J]. Annu Rev Pathol, 2020, 15: 23-50.
[11] IRUDAYASWAMY A, MUTHIAH M, ZHOU L, et al. Long-term fate of human fetal liver progenitor cells transplanted in injured mouse livers [J]. Stem Cells, 2018, 36(1): 103-113.
[12] PIETROSI G, VIZZINI G, GERLACH J, et al. Phases I-II matched case-control study of human fetal liver cell transplantation for treatment of chronic liver disease[J]. Cell Transplant, 2015, 24(8): 1627-1638.
[13] HUCH M, DORRELL C, BOJ S F, et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration[J]. Nature, 2013, 494(7436): 247-250.
[14] HUCH M, GEHART H, VAN BOXTEL R, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell, 2015, 160(1/2): 299-312.
[15] LU W Y, BIRD T G, BOULTER L, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity[J]. Nat Cell Biol, 2015, 17(8): 971-983.
[16] KATSUDA T, KAWAMATA M, HAGIWARA K, et al. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity[J]. Cell Stem Cell, 2017, 20(1): 41-55.
[17] YU B, HE Z Y, YOU P, et al. Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors[J]. Cell Stem Cell, 2013, 13(3): 328-340.
[18] HUANG W J, ZHOU X, FU G B, et al. The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction[J]. Theranostics, 2021, 11(11): 5539-5552.
[19] LIU W H, SONG F Q, REN L N, et al. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases[J]. J Cell Mol Med, 2015, 19(3): 511-520.
[20] HARN H J, LIN S Z, HUNG S H, et al. Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function[J]. Cell Transplant, 2012, 21(12): 2753-2764.
[21] LIU S R, GUO R H, HOU X L, et al. Adipose-tissue derived porcine mesenchymal stem cells efficiently ameliorate CCl4-induced acute liver failure in mice[J]. Cytotechnology, 2020, 72(3): 327-341.
[22] SASAJIMA H, MIYAGI S, KAKIZAKI Y, et al. Cytoprotective effects of mesenchymal stem cells during liver transplantation from donors after cardiac death in rats[J]. Transplant Proc, 2018, 50(9): 2815-2820.
[23] SHI D Y, ZHANG J N, ZHOU Q, et al. Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs[J]. Gut, 2017, 66(5): 955-964.
[24] LI Y H, XU Y, WU H M, et al. Umbilical cord-derived mesenchymal stem cell transplantation in hepatitis B virus related acute-on-chronic liver failure treated with plasma exchange and entecavir: a 24-month prospective study[J]. Stem Cell Rev and Rep, 2016, 12(6): 645-653.
[25] KIM Y H, CHO K A, PARK M, et al. Conditioned medium from tonsilderived mesenchymal stem cells relieves CCl4-induced liver fibrosis in mice[J]. Tissue Eng Regen Med, 2019, 16(1): 51-58.
[26] TAKEBE T, SEKINE K, ENOMURA M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant[J]. Nature, 2013, 499(7459): 481-484.
[27] TAKEBE T, SEKINE K, KIMURA M, et al. Massive and reproducible production of liver buds entirely from human pluripotent stem cells[J]. Cell Rep, 2017, 21(10): 2661-2670.
[28] WANG S Y, WANG X, TAN Z L, et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury[J]. Cell Res, 2019, 29(12): 1009-1026.
[29] HU H L, GEHART H, ARTEGIANI B, et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids[J]. Cell, 2018, 175(6): 1591-1606.
[30] SHIOTA J, ZAKI N H M, MERCHANT J L, et al. Generation of organoids from mouse extrahepatic bile ducts[J]. J Vis Exp, 2019(146): 10.3791/59544.
[31] RIMLAND C A, TILSON S G, MORELL C M, et al. Regional differences in human biliary tissues and corresponding in vitro-derived organoids[J]. Hepatology, 2021, 73(1): 247-267.
[32] ROOS F J M, WU H Y, WILLEMSE J, et al. Cholangiocyte organoids from human bile retain a local phenotype and can repopulate bile ducts in vitro[J]. Clin Transl Med, 2021, 11(12): e566. |
